159 related articles for article (PubMed ID: 32380477)
1. The shared KEGG pathways between icariin-targeted genes and osteoporosis.
Yu T; Xiong Y; Luu S; You X; Li B; Xia J; Zhu H; Zhao Y; Zhou H; Yu G; Yang Y
Aging (Albany NY); 2020 May; 12(9):8191-8201. PubMed ID: 32380477
[TBL] [Abstract][Full Text] [Related]
2. Shared KEGG pathways of icariin-targeted genes and osteoarthritis.
Liu Y; Mi B; Lv H; Liu J; Xiong Y; Hu L; Xue H; Panayi AC; Liu G; Zhou W
J Cell Biochem; 2019 May; 120(5):7741-7750. PubMed ID: 30506715
[TBL] [Abstract][Full Text] [Related]
3. Icariin abrogates osteoclast formation through the regulation of the RANKL-mediated TRAF6/NF-κB/ERK signaling pathway in Raw264.7 cells.
Kim B; Lee KY; Park B
Phytomedicine; 2018 Dec; 51():181-190. PubMed ID: 30466615
[TBL] [Abstract][Full Text] [Related]
4. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.
Hsieh TP; Sheu SY; Sun JS; Chen MH
Phytomedicine; 2011 Jan; 18(2-3):176-85. PubMed ID: 20554188
[TBL] [Abstract][Full Text] [Related]
5. Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu maxim.
Xue L; Jiang Y; Han T; Zhang N; Qin L; Xin H; Zhang Q
J Ethnopharmacol; 2016 Nov; 192():370-381. PubMed ID: 27422162
[TBL] [Abstract][Full Text] [Related]
6. Icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activation.
Song L; Zhao J; Zhang X; Li H; Zhou Y
Eur J Pharmacol; 2013 Aug; 714(1-3):15-22. PubMed ID: 23764463
[TBL] [Abstract][Full Text] [Related]
7. Icariin inhibits RANKL-induced osteoclastogenesis via modulation of the NF-κB and MAPK signaling pathways.
Xu Q; Chen G; Liu X; Dai M; Zhang B
Biochem Biophys Res Commun; 2019 Jan; 508(3):902-906. PubMed ID: 30538045
[TBL] [Abstract][Full Text] [Related]
8. Icariin protects against glucocorticoid induced osteoporosis, increases the expression of the bone enhancer DEC1 and modulates the PI3K/Akt/GSK3β/β-catenin integrated signaling pathway.
Hu J; Mao Z; He S; Zhan Y; Ning R; Liu W; Yan B; Yang J
Biochem Pharmacol; 2017 Jul; 136():109-121. PubMed ID: 28408345
[TBL] [Abstract][Full Text] [Related]
9. Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis.
An Y; Zhang H; Wang C; Jiao F; Xu H; Wang X; Luan W; Ma F; Ni L; Tang X; Liu M; Guo W; Yu L
FASEB J; 2019 Nov; 33(11):12515-12527. PubMed ID: 31461386
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E plays crucial roles in maintaining bone mass by promoting osteoblast differentiation via ERK1/2 pathway and by suppressing osteoclast differentiation via c-Fos, NFATc1, and NF-κB pathway.
Noguchi T; Ebina K; Hirao M; Otsuru S; Guess AJ; Kawase R; Ohama T; Yamashita S; Etani Y; Okamura G; Yoshikawa H
Biochem Biophys Res Commun; 2018 Sep; 503(2):644-650. PubMed ID: 29906458
[TBL] [Abstract][Full Text] [Related]
11. Icariin influences adipogenic differentiation of stem cells affected by osteoblast-osteoclast co-culture and clinical research adipogenic.
Zhang S; Feng P; Mo G; Li D; Li Y; Mo L; Yang Z; Liang D
Biomed Pharmacother; 2017 Apr; 88():436-442. PubMed ID: 28122309
[TBL] [Abstract][Full Text] [Related]
12. Icariin protects against glucocorticoid-induced osteoporosis in vitro and prevents glucocorticoid-induced osteocyte apoptosis in vivo.
Feng R; Feng L; Yuan Z; Wang D; Wang F; Tan B; Han S; Li T; Li D; Han Y
Cell Biochem Biophys; 2013 Sep; 67(1):189-97. PubMed ID: 23417569
[TBL] [Abstract][Full Text] [Related]
13. Icariin promotes osteogenic differentiation by suppressing Notch signaling.
Xu Y; Li L; Tang Y; Yang J; Jin Y; Ma C
Eur J Pharmacol; 2019 Dec; 865():172794. PubMed ID: 31733213
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the osteogenetic effects exerted on mesenchymal stem cell strain C3H10T1/2 by icariin via MAPK signaling pathway in vitro].
Mao XY; Bian Q; Shen ZY
Zhong Xi Yi Jie He Xue Bao; 2012 Nov; 10(11):1272-8. PubMed ID: 23158946
[TBL] [Abstract][Full Text] [Related]
15. Proanthocyanidins inhibit osteoclast formation and function by inhibiting the NF-κB and JNK signaling pathways during osteoporosis treatment.
Zhu W; Yin Z; Zhang Q; Guo S; Shen Y; Liu T; Liu B; Wan L; Li S; Chen X; Ouyang Z; Peng D
Biochem Biophys Res Commun; 2019 Jan; 509(1):294-300. PubMed ID: 30583865
[TBL] [Abstract][Full Text] [Related]
16. Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling.
Ming LG; Chen KM; Xian CJ
J Cell Physiol; 2013 Mar; 228(3):513-21. PubMed ID: 22777826
[TBL] [Abstract][Full Text] [Related]
17. The effect of icariin on bone metabolism and its potential clinical application.
Wang Z; Wang D; Yang D; Zhen W; Zhang J; Peng S
Osteoporos Int; 2018 Mar; 29(3):535-544. PubMed ID: 29110063
[TBL] [Abstract][Full Text] [Related]
18. Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner.
Wu Y; Xia L; Zhou Y; Xu Y; Jiang X
Cell Prolif; 2015 Jun; 48(3):375-84. PubMed ID: 25867119
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Mechanism of Icariin in Osteoporosis Based on a Network Pharmacology Strategy.
Long Z; Wu J; Xiang W; Zeng Z; Yu G; Li J
Med Sci Monit; 2020 Nov; 26():e924699. PubMed ID: 33230092
[TBL] [Abstract][Full Text] [Related]
20. Icariin prevents oestrogen deficiency-induced alveolar bone loss through promoting osteogenesis via STAT3.
Xu H; Zhou S; Qu R; Yang Y; Gong X; Hong Y; Jin A; Huang X; Dai Q; Jiang L
Cell Prolif; 2020 Feb; 53(2):e12743. PubMed ID: 31943455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
